当代治疗类风湿关节炎的方法:精确性和进展
Tania Gudu1, Mert Oztas2, Elena Nikiphorou3
1Rheumatology Department, Ipswich Hospital, East Suffolk North Essex NHS Foundation Trust (ESNEFT), Ipswich, UK; Essex ESNEFT Psychological Research Unit for Behaviour, Health and Wellbeing (EEPRU), Department of Psychology, University of Essex, Colchester, UK; Heath Road, Ipswich Hospital, Ipswich, IP4 5PD, UK.
Best practice & research. Clinical rheumatology
|October 2, 2025
概括
类风湿性关节炎 (RA) 治疗正在超越甲状腺素,新的生物和向合成药物提供了改进的选择. 精准医学和新兴疗法有望为RA患者提供更加个性化和有效的护理.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,影响关节和器官.
- 传统的合成疾病修饰性抗风湿药物 (csDMARDs) 是标准的,但对于近一半的患者来说往往是不足的.
- 关节炎治疗领域正在迅速发展.
研究的目的:
- 为 RA 提供当前和未来治疗环境的全面概述.
- 讨论新的治疗方法,精准医学和RA管理中的挑战.
- 探索基于生物标志物的治疗选择和以患者为中心的护理.
主要方法:
- 对标准疗法,生物DMARDs (向TNF-α,IL-6,B/T细胞) 和向合成DMARDs (JAK抑制剂) 的审查.
- 讨论新兴疗法,包括基于细胞的方法.
- 探索基于生物标志物的治疗选择 (自身抗体,成像,突组织) 和挑战 (治疗失败,安全性,并发症).
主要成果:
- 关节炎治疗领域已大幅扩大,包括多种生物和有针对性的合成DMARDs.
- 新兴的疗法和创新方法准备彻底改变RA治疗.
- 生物标志物驱动的选择,管理并发症和解决治疗失败是重点关注的关键领域.
结论:
- 未来的RA治疗可能会涉及先进的疗法,如机器学习和多omics,以患者为中心的方法为指导.
- 解决难以治疗的RA和药物安全仍然至关重要.
- 精准医学对优化RA患者的治疗结果具有显著的前景.
相关概念视频
01:21Rheumatic Heart Disease III: Medical Management
289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
01:20Rheumatic Heart Disease IV: Nursing Management
272
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
272
01:29Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
01:17Pericarditis III: Medical Management
313
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
313
01:26Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K